Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Carcinoma, Medullary × Dacarbazine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 9 Hodgkin Disease 5 Lymphoma 3 Sarcoma 2 Thyroid Neoplasms 1 Recurrence 1 Neoplasm Metastasis 1 Leiomyosarcoma 1 Carcinoma, Medullary 1

Interventions

vandetanib 2 pentetreotide 1 lenvatinib 1 cabozantinib 1 Sorafenib 1 Octreotide 1 Lithium Carbonate 1 Irinotecan 1 Imatinib Mesylate 1 Dacarbazine 1 Capecitabine 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00354523 2014-12-17

Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma

M.D. Anderson Cancer Center

Phase 1/2 Terminated

Thyroid Neoplasms, Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡